Clinical Study
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
Table 3
Multivariate analyses of progression-free survival in 117 ovarian cancer patients.
| Clinicopathological characteristics | B regression coefficient | Standard Error (B) | Hazard ratio | 95% CI (Hazard ratio) | value* |
| Age | −0.025 | 0.014 | 0.98 | 0.95–1.00 | 0.083 | FIGO stage | | | | | | I/II | | | 1.00 | | | III/IV | 1.814 | 0.502 | 6.13 | 2.29–16.4 | 0.0003 | Grade | | | | | | 1 | | | 1.00 | | | 2 | 0.750 | 0.778 | 2.12 | 0.46–9.73 | 0.34 | 3 | 0.617 | 0.769 | 1.85 | 0.41–8.36 | 0.42 | Residual tumor | | | | | | ≤1 cm | | | 1.00 | | | > cm | 0.858 | 0.277 | 2.35 | 0.83–2.30 | 0.002 | % E O C stem cells | | | | | | <20% CD44 Cells | | | 1.00 | | | >20% CD44 Cells | 0.893 | 0.416 | 2.44 | 1.08–5.52 | 0.032 |
|
|
*Cox regression model.
|